title: Methaemoglobinaemia secondary to treatment with trimethoprim and sulphamethoxazole associated with inhaled nitric oxide.
authors.forename: A
authors.initials: A
authors.lastname: López
authors.forename: B
authors.initials: B
authors.lastname: Bernardo
authors.forename: J
authors.initials: J
authors.lastname: López-Herce
authors.forename: A I
authors.initials: AI
authors.lastname: Cristina
authors.forename: A
authors.initials: A
authors.lastname: Carrillo
mesh_terms: D000280:Administration, Inhalation; D001932:Brain Neoplasms / Q000150:complications; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007223:Infant; D008708:Methemoglobinemia / Q000209:etiology*; D009447:Neuroblastoma / Q000150:complications; D009569:Nitric Oxide / Q000008:administration & dosage / Q000009:adverse effects*; D011020:Pneumonia, Pneumocystis / Q000188:drug therapy; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000009:adverse effects*
chemical_list: D009569:Nitric Oxide; D015662:Trimethoprim, Sulfamethoxazole Drug Combination